Neoadjuvant low-dose irradiation has been reported to program the differentiation of iNOS+ M1 macrophages by inducing endothelial cell activation and Th1 chemokine expression and by inhibiting the production of angiogenic factors, immunosuppressive factors, and tumor growth factors (56). The gene discussed is NOS2; the disease is neoplasm.